FDA Drug Application (205382) for INCRUSE ELLIPTA by GLAXO GRP ENGLAND

Back to FDA Applications sponsored by GLAXO GRP ENGLAND

Application Number205382
Product Number001
FormPOWDER;INHALATION
DosageEQ 62.5MCG BASE/INH
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code
Reference Drug
Drug NameINCRUSE ELLIPTA
Active IngredientUMECLIDINIUM BROMIDE



Back to FDA Applications sponsored by GLAXO GRP ENGLAND

Problems, Comments, Suggestions? Click here to contact Greg Thatcher

Please read my Disclaimer





Copyright (c) 2013 Thatcher Development Software, LLC. All rights reserved. No claim to original U.S. Gov't works.